BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1279831)

  • 1. Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators.
    Raasveld MH; Hack CE; ten Berge IJ
    Thromb Haemost; 1992 Sep; 68(3):264-7. PubMed ID: 1279831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.
    Nanninga PB; van Teunenbroek A; Veenhof CH; Büller HR; ten Cate JW
    Thromb Haemost; 1990 Nov; 64(3):361-4. PubMed ID: 1710832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of divided doses of steroids on side effects, cytokines, and activation of complement and granulocytes, coagulation and fibrinolysis after OKT3.
    Bemelman FJ; Buysmann S; Wilmink JM; Surachno S; Hack CE; Schellekens PT; ten Berge RJ
    Transplant Proc; 1994 Dec; 26(6):3096-7. PubMed ID: 7527944
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of coagulation and fibrinolysis during treatment with OKT3.
    ten Berge RJ; Raasveld MH; van Diepen FN; Hack CE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):566-7. PubMed ID: 8438416
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.
    de Boer JP; Creasy AA; Chang A; Roem D; Brouwer MC; Eerenberg AJ; Hack CE; Taylor FB
    Circ Shock; 1993 Jan; 39(1):59-67. PubMed ID: 7683256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kulik S; Głuszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):641-6. PubMed ID: 2465244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
    Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
    Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].
    Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):995-9. PubMed ID: 2148199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in coagulation and fibrinolysis in the postoperative period immediately after kidney transplantation in patients receiving OKT3 or cyclosporine A as induction therapy.
    Deira J; Alberca I; Lerma JL; Martín B; Tabernero JM
    Am J Kidney Dis; 1998 Oct; 32(4):575-81. PubMed ID: 9774117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.
    Sakon M; Kambayashi J; Taniguchi K; Yoshida T; Shiba E; Kawasaki T; Tsuji Y; Yukawa M; Murata K; Gotoh M
    Am J Gastroenterol; 1991 Dec; 86(12):1800-3. PubMed ID: 1660219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies.
    Hayashi M; Fukasawa I; Inaba N
    Int J Clin Pract; 2006 Oct; 60(10):1244-9. PubMed ID: 16669831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in plasma coagulation and fibrinolysis following cesarean section and relationship to deep venous thrombosis. Results of a randomized prospective comparative study with 6% hydroxyethyl starch 0.62 and low-dose heparin as thrombosis prophylaxis].
    Heilmann L; Hojnacki B; Ose C
    Z Geburtshilfe Perinatol; 1991; 195(4):176-81. PubMed ID: 1719708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.